Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?
Sep 24
U.S. Clinical Research and Equipment Industry Analysis
UpdatedSep 26, 2023
DataAggregated Company Financials
Companies77
- 7D-2.0%
- 3M-1.1%
- 1Y-1.0%
- YTD-6.9%
Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.0%, driven by a pullback from Illumina of 7.7%. In contrast, Alpha Teknova has gained 29%. Over the last year, the industry has been flat overall. As for the next few years, earnings are expected to grow by 16% per annum.
Industry Valuation and Performance
Has the U.S. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 26 Sep 2023 | US$674.7b | US$154.6b | US$11.2b | 33.7x | 60.2x | 4.4x |
| Thu, 24 Aug 2023 | US$713.3b | US$154.6b | US$11.2b | 32.8x | 63.6x | 4.6x |
| Sat, 22 Jul 2023 | US$741.4b | US$155.5b | US$12.7b | 29.4x | 58.4x | 4.8x |
| Mon, 19 Jun 2023 | US$704.3b | US$152.4b | US$12.5b | 29.3x | 56.3x | 4.6x |
| Wed, 17 May 2023 | US$672.0b | US$152.4b | US$12.6b | 28.2x | 53.2x | 4.4x |
| Fri, 14 Apr 2023 | US$744.3b | US$154.6b | US$10.8b | 30.7x | 68.9x | 4.8x |
| Sun, 12 Mar 2023 | US$693.6b | US$154.5b | US$10.9b | 29.6x | 63.9x | 4.5x |
| Tue, 07 Feb 2023 | US$758.4b | US$155.7b | US$9.1b | 31.5x | 83.3x | 4.9x |
| Thu, 05 Jan 2023 | US$734.2b | US$155.2b | US$8.8b | 28.9x | 83.7x | 4.7x |
| Sat, 03 Dec 2022 | US$781.0b | US$155.1b | US$8.8b | 28.9x | 89x | 5x |
| Mon, 31 Oct 2022 | US$720.5b | US$154.5b | US$13.0b | 27x | 55.6x | 4.7x |
| Wed, 28 Sep 2022 | US$699.1b | US$152.2b | US$17.3b | 23.8x | 40.4x | 4.6x |
| Fri, 26 Aug 2022 | US$803.5b | US$152.2b | US$17.3b | 31.1x | 46.4x | 5.3x |
| Sun, 24 Jul 2022 | US$787.5b | US$148.7b | US$20.2b | 32.1x | 39x | 5.3x |
| Tue, 21 Jun 2022 | US$674.6b | US$148.1b | US$20.1b | 27.5x | 33.6x | 4.6x |
| Thu, 19 May 2022 | US$731.6b | US$148.0b | US$20.0b | 31.5x | 36.5x | 4.9x |
| Sat, 16 Apr 2022 | US$839.5b | US$146.5b | US$25.3b | 36.4x | 33.1x | 5.7x |
| Mon, 14 Mar 2022 | US$792.0b | US$145.3b | US$25.2b | 33.5x | 31.5x | 5.5x |
| Wed, 09 Feb 2022 | US$859.1b | US$139.8b | US$26.9b | 38.8x | 31.9x | 6.1x |
| Fri, 07 Jan 2022 | US$916.3b | US$138.0b | US$27.3b | 42.6x | 33.5x | 6.6x |
| Sun, 05 Dec 2021 | US$942.0b | US$138.0b | US$27.3b | 43.1x | 34.5x | 6.8x |
| Tue, 02 Nov 2021 | US$766.1b | US$107.8b | US$21.5b | 49.2x | 35.6x | 7.1x |
| Thu, 30 Sep 2021 | US$720.1b | US$105.9b | US$18.6b | 48.7x | 38.6x | 6.8x |
| Sat, 28 Aug 2021 | US$727.9b | US$105.8b | US$18.7b | 52x | 39x | 6.9x |
| Sun, 04 Jul 2021 | US$656.3b | US$101.0b | US$17.6b | 39.3x | 37.2x | 6.5x |
| Wed, 07 Apr 2021 | US$569.5b | US$92.3b | US$15.4b | 38.8x | 37x | 6.2x |
| Sat, 09 Jan 2021 | US$553.9b | US$89.0b | US$14.2b | 39x | 39x | 6.2x |
| Fri, 02 Oct 2020 | US$450.0b | US$79.8b | US$11.8b | 38.6x | 38.2x | 5.6x |
Price to Earnings Ratio
38.2x
Current Industry PE
- Investors are optimistic on the American Life Sciences Tools and Services industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 60.2x which is higher than its 3-year average PE of 47.2x.
- The 3-year average PS ratio of 5.6x is higher than the industry's current PS ratio of 4.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 25% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Comparison
How does U.S. Clinical Research and Equipment compare with similar industries?
| US Market | -2.69% | |
| Healthcare | -1.09% | |
| Life Sciences | -2.02% | |
| Clinical Research and Equipment | -2.02% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| TKNO Alpha Teknova | US$2.31 | 29.1% +US$43.4m | -37.4% | PS2.4x | |
| OLK Olink Holding | US$15.04 | 1.9% +US$34.8m | 18.4% | PS12.8x | |
| BLFS BioLife Solutions | US$13.30 | 4.5% +US$24.8m | -38.4% | PS3.6x | |
| SHC Sotera Health | US$15.39 | 0.4% +US$17.0m | 113.5% | PS4.5x | |
| SLGC SomaLogic | US$2.34 | 2.6% +US$11.3m | -19.3% | PS4.3x |
